Association between lectin complement pathway initiators, C-reactive protein and left ventricular remodeling in

Mikkel Malby Schoos1, Lea Munthe-Fog, Mikkel-Ole Skjoedt

  • 1Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark. mikkel.schoos@gmail.com

Molecular Immunology
|February 13, 2013
PubMed

Insights

Ficolin-2, a lectin pathway component, is linked to left ventricular enlargement after myocardial infarction. Its interaction with C-reactive protein may influence infarct size and cardiac remodeling.

Area of Science:

  • Immunology
  • Cardiology
  • Complement System

Background:

  • Lectin pathway (LP) activation contributes to myocardial ischemia reperfusion injury (IRI).
  • LP involves mannose-binding lectin (MBL), ficolins-2 and -3, and MBL/Ficolin-associated Protein-1 (MAP-1).
  • The role of ficolins in IRI and their interaction with C-reactive protein (CRP) remain unclear.

Purpose of the Study:

  • To investigate the association of LP components and CRP with left ventricular (LV) volumes and infarct size in ST-segment elevation myocardial infarction (STEMI) patients.
  • To explore potential synergistic effects and interactions between LP components and CRP in the context of myocardial IRI and LV remodeling.

Main Methods:

  • Analysis of plasma samples from 55 STEMI patients.
  • Measurement of LP components (ficolin-2, MBL, ficolin-3, MAP-1) and CRP levels.
  • Assessment of LV end-systolic and end-diastolic volumes (ESV, EDV) and infarct size using cardiac magnetic resonance at 1-3 days and 6 months post-primary percutaneous coronary intervention.

Main Results:

  • Lower baseline ficolin-2 levels were observed compared to other LP components.
  • Elevated ficolin-2 levels correlated with increased LV ESV and EDV.
  • Synergistic association between high ficolin-2 and MBL levels with LV dilatation was noted.
  • The interaction between ficolin-2 and CRP was linked to larger infarct size and altered LV remodeling over 6 months.

Conclusions:

  • Ficolin-2, alone and in combination with MBL and MAP-1, is associated with LV dilatation post-myocardial infarction.
  • The interaction between ficolin-2 and CRP suggests a role in infarct size and LV remodeling, highlighting potential LP-pentraxin cross-activation in IRI.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...